Kymera Therapeutics, Inc. (KYMR) — DEF 14A Filings
All DEF 14A filings from Kymera Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Kymera Therapeutics DEF 14A: Executive Compensation Details
— Apr 29, 2025 Risk: low
Kymera Therapeutics, Inc. filed a DEF 14A on April 29, 2025, detailing executive compensation and other corporate governance matters. The filing covers the fisc -
Kymera Therapeutics, Inc. DEF 14A Filing
— Apr 24, 2024 Risk: low
Kymera Therapeutics, Inc. (KYMR) filed a Proxy Statement (DEF 14A) with the SEC on April 24, 2024. Kymera Therapeutics, Inc. filed a DEF 14A on April 24, 2024.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX